[1]
“An overview on comparative study of registration requirements for generics in US, Canada and Europe”, Int J Res Pharm Sci Technol, vol. 1, no. 4, pp. 117–123, Jun. 2020, doi: 10.33974/ijrpst.v1i4.196.